New research says, “There has been a significant fall in the number of cases of HPV, the virus that causes cervical cancer, following the introduction of a vaccine for young women.”
HPV vaccines are meant to fight back the high-risk infections. These high-risk infections contribute majorly to cervical cancers. Public Health England Data (2010 and 2016) shows that the rate of HPV infections decreased in women aged sixteen to twenty-one years. The decrease was found to about eighty-six per cent.
What is HPV?
For the women under the age of thirty-five years, cervical cancer is the most common type of cancer. Before the introduction of HPV vaccine, the disease took a toll of about eight hundred and fifty women per annum.
Mary Ramsay says, “These results are very promising and mean that in years to come we can expect to see significant decreases in cervical cancer. The study also reminds us how important it is to keep vaccination rates high to reduce the spread of this preventable infection. I encourage all parents of girls aged 12 to 13 to make sure they take up the offer for this potentially life-saving vaccine.” Mary Ramsay is the head of immunisation department at the Public Health England.
The vaccine to combat HPV was first introduced in the year 2008. HPV vaccine is delivered to girls (age group-12 to 18 years) through the schools. The vaccine is not meant for women above the age of about eighteen years.
If you see the current statistics, about eighty per cent of the people in the United Kingdom in the age group of fifteen to twenty-four years is now vaccinated. Joint Committee on Vaccination and Immunization is an expert advisory group to the health ministers. JCVI frequently conveys the health ministers that vaccinating boys with HPV vaccine will be cost-effective.